Dr Reddy’s Laboratories (RDY) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Dr. Reddy’s Laboratories has announced an investment of Rs. 649.99 crore in Aurigene Pharmaceutical Services Limited (APSL), a step-down wholly-owned subsidiary, to support its capital expenditure and working capital needs. APSL, a contract research and manufacturing organization, has been allocated over 1.16 billion equity shares by Aurigene Oncology Limited (AOL), another wholly-owned subsidiary. This strategic move is aimed at enhancing APSL’s capabilities in drug discovery and manufacturing.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
